The epidemiology of recurrent bacterial pneumonia in people with AIDS in Europe

Epidemiology and Infection

Volumn 133, Issue 2, 2005, Pages 237-243

  Puro, V ^a   Serraino, D ^a   Piselli, P ^a   Boumis, E ^a   Petrosillo, N ^a   Angeletti, C ^a   Ippolito, G ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; MACROLIDE; PNEUMOCOCCUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; BACTERIAL PNEUMONIA; CONFIDENCE INTERVAL; DATA ANALYSIS; EUROPE; FEMALE; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; RECURRENT INFECTION; RISK ASSESSMENT; WORLD HEALTH ORGANIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; EUROPE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; POPULATION SURVEILLANCE; RECURRENCE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; WORLD HEALTH ORGANIZATION;

EID: 15944381936     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268804003267     Document Type: Article

References (22)

1. Ancelle-Park RA. Expanded European AIDS case definition [Letter]. Lancet 1993; 341: 441.
2. Caiaffa WT, Graham NMH, Vlahov D. Bacterial pneumonia in adult population with human immunodeficiency virus (HIV) infection. Am J Epidemiol 1993; 138: 909-922.
3. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995; 333: 845-851.
4. Tumbarello M, Tacconelli E, de Gaetano Donati K, et al. Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18: 39-45.
5. Tumbarello M, Tacconelli E, de Gaetano Donati K, Cauda R. HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20: 208-209.
6. Ives NJ, Gazzard BG, Easterbrook PJ. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic. J Infect 2001; 42 134-139.
7. Sansone GR, Frengley JD. Impact of HAART on causes of death of persons with late-stage AIDS. J Urban Health 2000; 77: 166-175.
8. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS Surveillance in Europe. Mid-year Report, no. 63. Paris, France, 2000.
9. Serraino D, Dal Maso L, La Vecchia C, Franceschi S. Invasive cervical cancer as an AIDS-defining illness in Europe. AIDS 2002; 16 781-786.
10. Breslow NE, Day NE. The analysis of case-control studies. In: Statistical methods in cancer research, Vol. I. IARC Scientific Publication no. 32. Lyon: IARC Press, 1980.
11. Hosmer DW, Lemeshow S. Applied logistic regression, 2nd edn; 308-330. John Wiley & Sons, 2000.
12. StataCorp 2001. Stata Statistical Software: release 7.0. Stata Corporation, College Station, TX.
13. HIV and AIDS - United States, 1981-2000. MMWR 2001; 50: 430-434.
14. Mocroft A, Katlama C, Johnson AM, et al. AIDS across Europe, 1994-98: the EuroSIDA study. Lancet 2000; 356: 291-296.
15. Girardi E, Sampaolesi A, Gentile M, Nurra G, Ippolito G. Increasing proportion of late diagnosis of HIV infection among patients with AIDS in Italy following introduction of combination antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 25: 71-76.
16. Dore GJ, Li Y, McDonald A, Ree H, Kaldor JM, Kaldo JM. Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia. J Acquir Immune Defic Syndr 2002; 29: 388-395.
17. Wagner TM, Pezzotti P, Valdarchi C, Rezza G. Different pattern of AIDS-defining diseases in persons responding to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 26: 394-395.
18. Revised guidelines for HIV counselling, testing, and referral. MMWR 2001; 50 (RR-19): 1-57.
19. Greenberg AE, Thomas PA, Landesman SH, et al. The spectrum of HIV-related disease among outpatients in New York City. AIDS 1992; 6 849-859.
20. Chan IS, Neaton JD, Saravolatz LD, Crane LR, Osterberger J. Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community Programs for Clinical Research on AIDS. AIDS 1995; 9: 1145-1151.
21. Ajdacic-Gross V, Zellweger U, Wang J, Fleerackers Y, Somaini B. How complete is AIDS surveillance in Europe? An eagle eye comparison with mortality data. J Epidemiol Comm Health 2001; 55: 52-56.
22. Pierce AB, Hoy JF. Is the recommendation for pneumococcal vaccination of HIV patients evidence based? J Clin Virol 2001; 22: 255-261.